The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-Decyl-3-((S)-1-methyl-pyrrolidin-2-yl)-pyridinium iodide ID: ALA56296
PubChem CID: 10025698
Max Phase: Preclinical
Molecular Formula: C20H35IN2
Molecular Weight: 303.51
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCCCCCCCCC[n+]1cccc([C@@H]2CCCN2C)c1.[I-]
Standard InChI: InChI=1S/C20H35N2.HI/c1-3-4-5-6-7-8-9-10-16-22-17-11-13-19(18-22)20-14-12-15-21(20)2;/h11,13,17-18,20H,3-10,12,14-16H2,1-2H3;1H/q+1;/p-1/t20-;/m0./s1
Standard InChI Key: FCNGVUOMLWKVEV-BDQAORGHSA-M
Molfile:
RDKit 2D
23 23 0 0 0 0 0 0 0 0999 V2000
1.5792 -1.6792 0.0000 I 0 0 0 0 0 0 0 0 0 0 0 0
-1.7333 -0.7125 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.0125 0.5333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4125 0.5333 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.3000 0.9458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0125 -0.3000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4458 -0.3000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7333 -1.5375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0250 1.0833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7333 0.9458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4042 -0.2917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.1250 1.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4458 0.5250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6917 1.8375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0208 -1.9500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1125 -6.4750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1167 -5.6500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3083 -3.1792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3083 -4.0042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4042 -4.4167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4042 -5.2375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0208 -2.7667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8292 -6.8875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3 6 1 0
4 5 1 0
5 3 1 6
6 2 2 0
7 2 1 0
8 2 1 0
9 4 1 0
10 13 1 0
11 4 1 0
12 5 1 0
13 7 2 0
14 12 1 0
15 8 1 0
16 17 1 0
17 21 1 0
18 22 1 0
19 18 1 0
20 19 1 0
21 20 1 0
22 15 1 0
23 16 1 0
3 10 2 0
9 14 1 0
M CHG 2 1 -1 2 1
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 303.51Molecular Weight (Monoisotopic): 303.2795AlogP: 4.88#Rotatable Bonds: 10Polar Surface Area: 7.12Molecular Species: NEUTRALHBA: 1HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 2HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 7.64CX LogP: 1.21CX LogD: 0.77Aromatic Rings: 1Heavy Atoms: 22QED Weighted: 0.44Np Likeness Score: 0.31
References 1. Crooks PA, Ayers JT, Xu R, Sumithran SP, Grinevich VP, Wilkins LH, Deaciuc AG, Allen DD, Dwoskin LP.. (2004) Development of subtype-selective ligands as antagonists at nicotinic receptors mediating nicotine-evoked dopamine release., 14 (8): [PMID:15050618 ] [10.1016/j.bmcl.2003.10.074 ] 2. Ayers JT, Dwoskin LP, Deaciuc AG, Grinevich VP, Zhu J, Crooks PA.. (2002) bis-Azaaromatic quaternary ammonium analogues: ligands for alpha4beta2* and alpha7* subtypes of neuronal nicotinic receptors., 12 (21): [PMID:12372503 ] [10.1016/s0960-894x(02)00687-x ] 3. Matera C, Pucci L, Fiorentini C, Fucile S, Missale C, Grazioso G, Clementi F, Zoli M, De Amici M, Gotti C, Dallanoce C.. (2015) Bifunctional compounds targeting both D2 and non-α7 nACh receptors: design, synthesis and pharmacological characterization., 101 [PMID:26164842 ] [10.1016/j.ejmech.2015.06.039 ]